Presymptomatic genetic testing with an APP mutation in Early-onset Alzheimer disease: A descriptive study of sibship dynamics

Journal of Genetic Counseling

Volumn 9, Issue 4, 2000, Pages 327-341

  Quaid, Kimberly A ^a   Murrell, Jill R ^a   Hake, Ann M ^a   Farlow, Martin R ^a   Ghetti, Bernardino ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer disease; Genetic counseling; Predictive testing

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; HUMAN; REVIEW; SIBLING;

EID: 0033927573     PISSN: 10597700     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009406229745     Document Type: Review

References (22)

1. Blacker D, Tanzi RE (1998) The genetics of Alzheimer disease: Current status and future prospects. Arch Neurol 55:294-296.
2. DeGrazia D (1991) The ethical justification for minimal paternalism in the use of the predictive test for Huntington's disease. J Clin Ethics 2:219-228.
3. Goate AM, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Guiffra L, Haynes A, Hardy JA (1991) Segregation of a missense mutations in the amyloid precursor protein gene with familial Alzheimer disease. Nature 349:704-706.
4. Hardy J (2000) APP Mutations Directory, Alzheimer Research Forum On-line Resources at www. alzforum.org, January 26, 2000.
5. Hendricks M, van Duijn CM, Cras P (1992) Presenile dementia and cerebral hemorrhage linked to a mutation at codon 692 of the B-amyloid precursor protein gene. Na Genet 1:218-221.
6. Huntington Disease Society of America (1989) Guidelines for Predictive Testing for Huntington Disease. New York: Huntington Disease Society of America.
7. Huntington Disease Society of America (1994) Revised Guidelines for Predictive Testing for Huntington Disease. New York: Huntington's Disease Society of America.
8. Karlinsky H (1998) Genetic testing and counseling for early-onset autosomal dominant Alzheimer disease. In: Post SG, Whitehouse PJ (eds) Genetic Testing for Alzheimer Disease: Ethical and Clinical Issues. Baltimore: Johns Hopkins University Press, pp. 103-117.
9. Karlinsky H, Vaula G, Haines JL, Ridgley J, Bergeron C, Mortilla M, Tupler R, Percy M, Robitaille Y, Crapper-MacLachlan DR, St. George Hyslop PH (1992) Molecular and prospective phonotypic characterization of a pedigree with familial Alzheimer disease and a missense mutation in codon 717 of the β-amyloid precursor protein (APP) gene. Neurology 42:1445-1453.
10. Lannfelt L, Axelman K, Lilius L, Basun H (1995) Genetic counseling of a Swedish Alzheimer family with amyloid precursor protein mutation. Am J Hum Genet 56:332-335.
11. Lennox A, Karlinsky H, Meschino W, Buchanan JA, Percy ME, Berg JM (1994) Molecular genetic predictive testing for Alzheimer disease: Deliberations and preliminary recommendations. Alzheimer Dis Assoc Disorders 8:126-147.
12. Levy-Lehad E, Wasco W, Poorkaj P, Romano EM, Oshima J, Pettingell WH, Yu C, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu YH, Guenette SY, Galas D, Nemens E, Wijsman EM, Bird TD, Schellenberg GD, Tanzi RE (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269:973-977.
13. Mullan MJ, Crawford F, Axelman K (1992) A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of B-amyloid. Nat Genet 1:345-347.
14. Murrell J, Farlow M, Ghetti B, Benson MD (1991) A mutation in the amyloid precurson protein associated with hereditary Alzheimer's disease. Science 254:97-99.
15. Murrell JR, Hake A, Quaid KA, Farlow MR (2000) Early-onset Alzheimer disease caused by a new mutation (V717L) in the APP gene. Arch Neurol.
16. Post SG, Whitehouse PJ, Zinn AB (1998) Introduction: Genetics and the moral future of dementia care. In: Post SG, Whitehouse PJ (eds) Genetic Testing for Alzheimer Disease: Ethical and Clinical Issues. Baltimore: Johns Hopkins University Press.
17. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, Mar L, Sorbi S, Nacmias B, Piacentini S, Amaducci L, Chumakov I, Cohen D, Lannfelt L, Fraser PE, Rommens JM, St. George-Hyslop PH (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to Alzheimer disease type 3 gene. Nature 376:776-778.
18. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Dasilva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St. George-Hyslop, PH (1995) Cloning of the gene bearing missense mutations in early-onset familial Alzheimer disease. Nature 375:754-760.
19. Smith DH, Quaid KA, Dworkin RB, Gramelspacher GP, Granbois JA, Vance GH (1998) Early Warning: Cases and Ethical Guidance for Presymptomatic Testing in Genetic Diseases. Indianapolis: Indiana University Press.
20. Tibben A, Stevens M, Wert GMWR, Niermeijer MF, van Duijn CM, van Swieten JC (1997) Preparing for presymptomatic DNA testing for early onset Alzheimer's disease/cerebral haemorrhage and hereditary Pick disease. J Med Genet 34:63-72.
21. World Federation of Neurology, Predictive Testing Committee, Research Group on Huntington's Chorea (1990) Ethical issues policy statement on Huntington's disease molecular genetics predictive test. J Med Genet 27:34-38.
22. World Federation of Neurology, Predictive Testing Committee, Research Group on Huntington's Chorea (1994) Guidelines for molecular genetics predictive test in Huntington Disease. Neurology 44:1533-1536.